1. Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers.
- Author
-
Maia, Juliana Marino, de Oliveira, Bruna Stefane Alves, Branco, Luiz G.S., and Soriano, Renato Nery
- Subjects
- *
PSILOCYBIN , *SEROTONIN receptors , *HALLUCINOGENIC drugs , *POST-traumatic stress disorder , *GLUTAMATE receptors , *REWARD (Psychology) , *AMYGDALOID body - Abstract
Psychedelics (serotonergic hallucinogens) are psychoactive substances that can alter perception and mood, and affect cognitive functions. These substances activate 5-HT 2A receptors and may exert therapeutic effects. Some of the disorders for which psychedelic-assisted therapy have been studied include depression, addiction, anxiety and post-traumatic stress disorder. Despite the increasing number of studies reporting clinical effectiveness, with fewer negative symptoms and, additionally, minimal side effects, questions remain to be explored in the field of psychedelic medicine. Although progress has been achieved, there is still little understanding of the relationship among human brain and the modulation induced by these drugs. The present article aimed to describe, review and highlight the most promising findings in the literature regarding the (putative) therapeutic effects of psychedelics. • Psychedelics are close structural analogs of serotonin (5-HT). • Activation of the 5-HT 2A receptor by psychedelics induces glutamate release. • Psychedelics may cause an increase in the connectivity between amygdala and m-PFC. • Psychedelic therapy is associated with decreased frontoparietal connectivity. • Therapy with psychedelics showed that small doses can cause beneficial outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF